In agreement with our results, previous studies detected a higher level of ET-1 in patients with IR for example, obesity [29], diabetes mellitus [30], as well as impaired glucose tolerance [31]. Here, EDN1 is linked to obesity due to melanocortin 4 receptor deficiency.